ResMed is taking a “smart devices” and Big Data approach to further entrench itself as one of the two leading players in the global obstructive sleep apnea, or OSA, market. With cloud ...

Management acknowledged potential risks related to global trade and tariffs but confirmed that ResMed's medical devices are exempt, mitigating financial impacts. Analysts highlighted the need to ...

SAN DIEGO (AP) — SAN DIEGO (AP) — ResMed Inc. (RMD) on Wednesday reported fiscal third-quarter profit of $365 million. On a per-share basis, the San Diego-based company said it had profit of ...

Resmed produces sleep apnoea machines and accompanying technology in Singapore and Australia, and the $49bn company confirmed this week its existing tariff exemption will continue in the US.

ResMed RMD is gearing up to announce its quarterly earnings on Wednesday, 2025-04-23. Here's a quick overview of what investors should know before the release. Analysts are estimating that ResMed ...

SAN DIEGO, April 21, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the global leader in health technology focused on sleep, breathing, and care delivered in the home, today announced the ...

SAN DIEGO, April 21, 2025 (GLOBE NEWSWIRE) — Resmed (NYSE: RMD, ASX: RMD), the global leader in health technology focused on sleep, breathing, and care delivered in the home, today announced the ...